申请人:GEORGETOWN UNIVERSITY
公开号:US20140135325A1
公开(公告)日:2014-05-15
The invention encompasses compound and pharmaceutical composition comprising the compound of the following Formula (I): or pharmaceutically acceptable salts or prodrugs thereof, that are useful for inhibiting ezrin protein in a cell or for inhibiting the growth of a cancer cell.